Kisspeptin for Fertility: What the Research Shows | telos rx
Smiling couple embracing outdoors in a golden field, illustrating kisspeptin fertility research
← Back to blog
fertility

Kisspeptin for Fertility: What the Research Shows

By TelosRX Editorial Team Updated

Kisspeptin for fertility is still investigational. Small clinical trials show it can trigger egg maturation in IVF and raise reproductive hormones, but it isn't FDA-approved for any use. TelosRX walks through what the studies actually found.

Most hormones get famous for what they do in the body. Kisspeptin got famous for what goes wrong without it. People born with faulty kisspeptin signaling often never go through normal puberty.

That discovery turned a little-known brain peptide into one of the most studied targets in reproductive medicine. Here's what the human research shows so far, study by study.

What Kisspeptin Is, in Plain English

Kisspeptin is a peptide made in the hypothalamus, a hormone control center in the brain. It switches on GnRH neurons. Those neurons tell the pituitary to release LH and FSH, the hormones that drive ovulation and sperm production.

Think of it as the top of the reproductive chain of command. Researchers mainly study two forms: kisspeptin-54 (longer, lasts longer in blood) and kisspeptin-10 (shorter, faster-acting).

Kisspeptin is not FDA-approved. Every study below used it under research protocols with close monitoring.

Finding 1: Kisspeptin Is Required for Normal Puberty

In 2003, two research groups made the same discovery. Kisspeptin receptor mutations cause hypogonadotropic hypogonadism, meaning absent or delayed puberty (de Roux et al., PNAS, 2003; Seminara et al., NEJM, 2003).

That human genetic evidence is why kisspeptin is now seen as a gatekeeper of fertility. It is also why scientists asked whether giving kisspeptin could restart a stalled reproductive axis.

Finding 2: Kisspeptin Raises LH in Healthy Volunteers

In early human work, infused kisspeptin-54 raised LH in healthy men (Dhillo et al., J Clin Endocrinol Metab, 2005). It was a proof-of-concept that the peptide works in people, not just animals.

A later study in healthy men found kisspeptin-10 boluses produced a fast, dose-dependent LH rise. Continuous infusion increased LH pulse frequency and testosterone (George et al., J Clin Endocrinol Metab, 2011).

Finding 3: Mixed Results in Hypothalamic Amenorrhea

Hypothalamic amenorrhea means periods stop because the brain's reproductive signal goes quiet, often from low energy availability or stress.

A single kisspeptin-54 injection stimulated reproductive hormones in these women. But twice-daily dosing led to tachyphylaxis — the body stops responding with repeated doses (Jayasena et al., J Clin Endocrinol Metab, 2009).

A follow-up tested twice-weekly injections for 8 weeks. Reproductive hormones stayed higher than with saline. Desensitization was only partial, and no adverse effects were reported (Jayasena et al., Clin Pharmacol Ther, 2010). The study was small, and it measured hormones, not pregnancies.

Finding 4: Kisspeptin Can Trigger Egg Maturation in IVF

In IVF, a "trigger" shot prompts eggs to finish maturing before retrieval. Standard triggers include hCG or a GnRH agonist.

In a 53-woman trial, a single kisspeptin-54 injection triggered egg maturation at every dose tested. Embryo transfer happened in 49 women, and 12 had a clinical pregnancy, about 23% (Jayasena et al., J Clin Invest, 2014).

That rate was lower than typical IVF benchmarks. The authors framed it as proof-of-concept, not a replacement for standard care.

Finding 5: A Possible Safety Edge for High-Risk IVF Patients

Ovarian hyperstimulation syndrome (OHSS) is a serious IVF complication where the ovaries overreact. hCG triggers are linked to higher OHSS risk in some patients.

Researchers reasoned kisspeptin might be gentler, because it works through the body's own GnRH signal. A phase 2 trial of 60 women at high OHSS risk tested this idea (Abbara et al., J Clin Endocrinol Metab, 2015). The authors reported effective egg maturation with low rates of OHSS.

A later randomized trial of 62 high-risk women gave a second kisspeptin dose 10 hours after the first. It produced more LH release and better egg yield in more patients. The authors reported no moderate or severe OHSS (Abbara et al., Hum Reprod, 2017).

Finding 6: Early Signals on Sexual Desire

Kisspeptin also acts in brain regions tied to arousal. In functional MRI studies, kisspeptin increased activity in sexual and emotional brain networks in healthy men (Comninos et al., J Clin Invest, 2017).

Small follow-up studies in men and women with low sexual desire reported similar brain-activity changes (published in JAMA Network Open, 2022–2023). These are imaging findings, not proof of a meaningful real-world effect.

If libido is your main interest, there is an FDA-approved option for one specific indication: bremelanotide (Vyleesi) for premenopausal women with acquired generalized HSDD. Compounded PT-141 is a separate, not FDA-approved preparation. Explore PT-141 at TelosRX, subject to medical approval by a licensed provider.

The Studies at a Glance

Study Population Form Size Main finding
Dhillo 2005 Healthy men Kisspeptin-54 IV Small Raised LH
Jayasena 2009 Women with HA Kisspeptin-54 Small Single dose worked; twice-daily caused tachyphylaxis
Jayasena 2010 Women with HA Kisspeptin-54, twice weekly Small Higher hormones vs saline at 8 weeks
George 2011 Healthy men Kisspeptin-10 Small Higher LH pulse frequency and testosterone
Jayasena 2014 Women in IVF Kisspeptin-54 trigger 53 Egg maturation; 23% clinical pregnancy
Abbara 2015 High OHSS-risk IVF Kisspeptin-54 trigger 60 Egg maturation with low OHSS rates
Abbara 2017 High OHSS-risk IVF Two kisspeptin-54 doses 62 Better egg yield; no moderate or severe OHSS

What the Research Does Not Show

  • No large trials. Most studies enrolled dozens of people, not thousands.
  • Mostly one research center. Much of the human work comes from a single London group, so independent replication is limited.
  • No approval. Kisspeptin is not FDA-approved for fertility or anything else.
  • No home-use protocol. Trials used carefully timed doses alongside standard fertility monitoring. Results don't translate to self-directed use.
  • Hormone changes aren't births. Several studies measured LH, not pregnancy or live birth.

Kisspeptin-10 vs Kisspeptin-54: Why the Form Matters

Kisspeptin-10 clears from blood in minutes. That makes it useful for studying hormone pulses. Kisspeptin-54 lasts longer, which is why it was chosen for IVF trigger studies.

Online sellers often blur the two. Doses from one form don't carry over to the other. Our kisspeptin-10 research overview covers that form in more depth.

How This Fits With Other Hormone Approaches

Kisspeptin sits at the top of the reproductive axis. Gonadorelin acts one step lower, mimicking GnRH itself. Our article on gonadorelin and fertility research explains that difference.

For a broader look at kisspeptin's hormone effects beyond fertility, see our kisspeptin hormone research explainer.

What to Do if You're Trying to Conceive

Start with a reproductive endocrinologist or fertility specialist. They can run hormone testing and discuss proven options. If you're interested in a kisspeptin clinical trial, ask them about enrolling studies.

TelosRX does not offer fertility care. Our online-first, asynchronous service focuses on areas like weight, hormones and wellness, with every prescription subject to medical approval by a licensed provider.

Frequently Asked Questions

Is kisspeptin FDA-approved for fertility?

No. Kisspeptin is not FDA-approved for fertility or any other use. Human studies have used it under research protocols, mainly to study IVF egg-maturation triggers and hormone signaling. Any use outside a clinical trial would be off-label and experimental. Talk with a fertility specialist about approved options and whether a clinical trial might be appropriate for you.

Can kisspeptin help you get pregnant?

Small trials show kisspeptin-54 can trigger egg maturation in IVF, and some women in those studies became pregnant. In one 53-woman trial, about 23% had a clinical pregnancy. That is proof-of-concept, not proof that kisspeptin improves pregnancy odds versus standard triggers. Larger, independent trials are still needed before conclusions can be drawn.

Does kisspeptin increase testosterone in men?

Research suggests it can raise testosterone short-term. A 2011 study in healthy men found kisspeptin-10 increased LH pulse frequency and testosterone during infusion. These were brief, closely monitored experiments. Long-term effects, safety and real-world benefit in men with low testosterone have not been established, and kisspeptin is not FDA-approved for this purpose.

What is the difference between kisspeptin-10 and kisspeptin-54?

Both activate the same receptor, but they differ in length and duration. Kisspeptin-10 is a short fragment that clears from the blood within minutes. Kisspeptin-54 is longer and stays active longer, which is why IVF trigger studies used it. Doses and effects from one form don't transfer to the other.

Is kisspeptin safe?

In small clinical studies, kisspeptin was generally well tolerated under close monitoring, with few reported adverse effects. However, the total number of people studied is small, long-term data are lacking, and products sold online may vary in purity. Safety in real-world, unsupervised use is unknown. Any hormone-related therapy should be guided by a licensed provider.

Does kisspeptin help with hypothalamic amenorrhea?

Early research is mixed. A single kisspeptin injection raised reproductive hormones in women with hypothalamic amenorrhea, but twice-daily dosing caused the body to stop responding. Twice-weekly injections over 8 weeks kept hormones higher than saline. These studies measured hormone levels, not restored cycles or pregnancies, so clinical benefit remains unproven.

TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.

Start your private evaluation at TelosRX.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX